Almagro, Pere
Soler-Cataluña, Juan José
Huerta, Arturo
González-Segura, Diego
Cosío, Borja G.
,
Article History
Received: 6 June 2023
Accepted: 9 November 2023
First Online: 2 January 2024
Declarations
:
: The study protocol was approved by the Research Ethics Committee of the Hospital Clinic of Barcelona (Spain), and procedures were performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects and/or their legal guardian(s).
: Not applicable.
: Pere Almagro declares he has received speaking or advisory fees, or economic aid to attend congresses from Astra-Zeneca, GSK, Novartis, Chiesi, Menarini, Boehringer-Ingelheim, Ferrer, and Rovi. Borja G Cosío declares he has received speaking or advisory fees, or economic aid to attend congresses from Astra-Zeneca, GSK, Novartis, Chiesi, Mundipharma, Menarini, Sanofi, TEVA, Boehringer-Ingelheim, and Rovi. He also reports non-financial support from Separ. Juan José Soler-Cataluña has received speaker fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, GSK, Menarini, and consulting fees from Bial, Boehringer Ingelheim, Chiesi and GSK. Diego González-Segura is an employee of Chiesi España SAU, the sponsor of the study. The authors report no other conflicts of interest in this work.